Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00351299 · ClinicalTrials.gov registry record · Phase 2
Randomized Controlled Trial of Dexmedetomidine for the Treatment of Intensive Care Unit (ICU) Delirium
A Phase 2 study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- Phase 2
- Development phase
- 53
- Enrollment target
NCT00351299 is a Phase 2 study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 53 participants.
The verdict
NCT00351299, a Phase 2 study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 53 participants
- Enrollment target
Study Summary
The purpose of the research is to see if dexmedetomidine (a drug that has a calming effect - a sedative) is effective for the treatment of acute delirium
Interventions
- OTHER Standard of Care
- DRUG Dexmedetomidine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2006-01 |
| Est. Completion | 2012-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00351299
The ClinicalTrials.gov registry entry for NCT00351299 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.
NCT00351299 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00351299 about?
NCT00351299 is a clinical study titled "Randomized Controlled Trial of Dexmedetomidine for the Treatment of Intensive Care Unit (ICU) Delirium". The purpose of the research is to see if dexmedetomidine (a drug that has a calming effect - a sedative) is effective for the treatment of acute delirium
What is the current status of trial NCT00351299?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 53 participants. The study started on 2006-01. Estimated completion is 2012-10.
What interventions are being tested in trial NCT00351299?
The interventions under investigation include: Standard of Care (OTHER), Dexmedetomidine (DRUG).
Who is sponsoring clinical trial NCT00351299?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.